mounjaro tirzepatide patent expiration date The upcoming expiry of the semaglutide in India in mid-March 2026 is expected to transform the country's diabetes treatment landscape. Ahead of this, industry experts predict that the development will open Indian pharma giant Cipla inks

Learn how to store and transport your medication without getting held up at TSA, whether its okay to skip a dose and more.

Reduce hair fall by 30% in two months, and stimulate hair follicle growth by 200%

This formulation guarantees quick absorption, effectively curbing hunger and cravings to assist you in achieving your weight loss goals

In the SURPASS-4 trial, patients receiving tirzepatide experienced an average weight loss of 7.1 kg (15.7 lbs) after 52 weeks, compared to 2.5 kg (5.5 lbs) in the insulin glargine group[6]. The SURMOUNT-1 trial tested the ability of tirzepatide to produce weight loss in people with obesity who do not have diabetes

2 weeks to firmer, more elastic skin**

What it is: A clinically recommended subcutaneous GLP-1 receptor agonist injection system engineered explicitly for the introductory starter phase of long-term weight reduction and metabolic adaptation